On November 10, 2018 Dendrogenix a company developing a innovative therapies, reported a first funding round of €3.6M, including €1.2M in capital and €2.4M in grants and recoverable advances from walloon region (Press release, Dendrogenix, NOV 10, 2018, View Source [SID1234539438]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!